Patents by Inventor Danielle Diperna

Danielle Diperna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG DELIVERY COMPOSITION AND METHOD OF FABRICATION
    Publication number: 20210177760
    Abstract: The methods of manufacture of a drug delivery composition. In some aspects, the methods include providing an organic phase, a biologically active ingredient, and an aqueous phase with a desirable pH (e.g., a pH at which the active ingredient has increased solubility in the aqueous phase compared to at neutral pH). After mixing of one or more of the aforementioned components, the resultant mixture is processed to provide the desired drug delivery composition.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 17, 2021
    Inventors: Rachael Sirianni, Kyle Householder, Danielle Diperna
  • Drug delivery composition and method of fabrication
    Patent number: 10952967
    Abstract: The methods of manufacture of a drug delivery composition. In some aspects, the methods include providing an organic phase, a biologically active ingredient, and an aqueous phase with a desirable pH (e.g., a pH at which the active ingredient has increased solubility in the aqueous phase compared to at neutral pH). After mixing of one or more of the aforementioned components, the resultant mixture is processed to provide the desired drug delivery composition.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: March 23, 2021
    Assignee: Dignity Health
    Inventors: Rachael Sirianni, Kyle Householder, Danielle Diperna
  • DRUG DELIVERY COMPOSITION AND METHOD OF FABRICATION
    Publication number: 20200054562
    Abstract: The methods of manufacture of a drug delivery composition. In some aspects, the methods include providing an organic phase, a biologically active ingredient, and an aqueous phase with a desirable pH (e.g., a pH at which the active ingredient has increased solubility in the aqueous phase compared to at neutral pH). After mixing of one or more of the aforementioned components, the resultant mixture is processed to provide the desired drug delivery composition.
    Type: Application
    Filed: May 9, 2018
    Publication date: February 20, 2020
    Inventors: Rachael Sirianni, Kyle Householder, Danielle Diperna